Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026)
Powered by 
Analysis
Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -99.85% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -5.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.70% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 10.87% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19.14% |
| 10 | Gyre Therapeutics | 691.38 Mn | 633.98 Mn | 26.90 Mn | 16.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.59% |
| Mar 31, 2026 | 0.23% |
| Dec 31, 2025 | 15.36% |
| Sep 30, 2025 | -3.41% |
| Jun 30, 2025 | -1.14% |
| Mar 31, 2025 | -0.20% |
| Dec 31, 2024 | 2.54% |
| Mar 31, 2024 | 2,356,300.00% |
| Dec 31, 2023 | 31.50% |
| Mar 31, 2023 | -99.88% |
| Dec 31, 2022 | 1,725.67% |
| Sep 30, 2022 | -88.63% |
| Jun 30, 2022 | -76.02% |
| Mar 31, 2022 | 124.35% |
| Dec 31, 2021 | 124.02% |
| Sep 30, 2021 | 148.52% |
| Jun 30, 2021 | 42.20% |
| Mar 31, 2021 | 29.05% |
| Dec 31, 2020 | 42.43% |
| Sep 30, 2020 | 29.50% |